FLT3 and acute myeloid leukemia: Utilizing an alternative FLT3-ITD positive AML cell line, MV4-11, we demonstrated that the range of synergy was 20–200 nM selinexor with 3–20 nM midostaurin or 0.5–8 nM gilteritinib.